Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Sep. 30, 2020	Sep. 30, 2019
Net revenue:
Total net revenue	[1]	$ 85,332	$ 89,577
Cost of revenue:
Total cost of revenue	[2]	49,929	56,634
Gross profit		35,403	32,943
Operating expenses:
Research and development		12,148	13,341
Selling and marketing		8,898	13,266
General and administrative		8,889	10,616
Total operating expenses		29,935	37,223
Income (loss) from operations		5,468	(4,280)
Loss on equity method investment, net		(28)
Other expense, net		(4,694)	(4,439)
Income (loss) before provision for income taxes		746	(8,719)
Provision for income taxes		344	637
Net income (loss)		$ 402	$ (9,356)
Net income (loss) per share - basic		$ 0.00	$ (0.11)
Net income (loss) per share - diluted		$ 0.00	$ (0.11)
Weighted average common shares used in computing net income (loss) per share:
Basic		91,194	88,772
Diluted		91,681	88,772
Net income (loss)		$ 402	$ (9,356)
Foreign currency translation adjustment		1,493	(1,018)
Comprehensive income (loss)		1,895	(10,374)
Products
Net revenue:
Total net revenue		31,258	37,605
Cost of revenue:
Total cost of revenue		18,426	21,570
Services
Net revenue:
Total net revenue		54,074	51,972
Cost of revenue:
Total cost of revenue		$ 31,503	$ 35,064

[1] Includes sales to the China joint venture, an equity method investment of $4,951 and $3,817 for three months ended September 30, 2020 and 2019, respectively. See Note 14.

[2] Includes cost of revenue from sales to the China joint venture, an equity method investment of $1,944 and $2,491 for the three months ended September 30, 2020 and 2019, respectively. See Note 14.